Cargando…
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Tumor infiltrating lymphocytes (TIL) play an essential role in mediating response to chemotherapy and improving clinical outcomes in all subtypes of breast cancer. Triple negative breast cancers (TN) are most likely to have tumors with >50 % lymphocytic infiltrate, termed lymphocyte predominant b...
Autores principales: | Stanton, Sasha E., Disis, Mary L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067916/ https://www.ncbi.nlm.nih.gov/pubmed/27777769 http://dx.doi.org/10.1186/s40425-016-0165-6 |
Ejemplares similares
-
Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients
por: Stanton, Sasha E., et al.
Publicado: (2021) -
Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2015) -
Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology
por: Kang, Byung Woog, et al.
Publicado: (2017) -
The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer
por: He, Mengdi, et al.
Publicado: (2021) -
Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
por: Cohen, Ivan J, et al.
Publicado: (2017)